Last reviewed · How we verify
Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies
Approved treatments
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
- 6-tioguanine+Standard Maintenance Therapy · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies patent landscape — cliff calendar, originator estates, attackable patents
- Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies treatment landscape brief
- Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies treatment updates RSS
Frequently asked questions about Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies
What drugs treat Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies?
Tracked treatments include 6-tioguanine+Standard Maintenance Therapy.
What is the treatment for Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies?
Standard treatment for Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies includes 6-tioguanine+Standard Maintenance Therapy. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies patent cliff · Polycythemia vera (PV) in adult patients who are refractory or resistant to other therapies CI report
- Treatment: 6-tioguanine+Standard Maintenance Therapy · Pfizer
- Treatment: 6-tioguanine+Standard Maintenance Therapy · Pfizer
- Treatment: 6-tioguanine+Standard Maintenance Therapy · Pfizer
- Treatment: 6-tioguanine+Standard Maintenance Therapy · Pfizer
- Treatment: 6-tioguanine+Standard Maintenance Therapy · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing